Skip to main content Help with accessibility Skip to main navigation

ESKETAMINE nasal spray (Spravato®▼) for treatment-resistant depression

CCG Approval Status:

Ha
Kn
Li
SF
SS
SH
Wa
WL
Wi
Date Added: 26 - Jan - 2023
Body System:
Black
ESKETAMINE nasal spray (Spravato®▼) for treatment-resistant depression

The Cheshire and Merseyside Interim Area Prescribing Group does not recommend the prescribing of ESKETAMINE nasal spray (Spravato®▼) for treatment-resistant depression in adults in accordance with NICE TA854.

NHS Cheshire and Merseyside APPROVED